NOTCH2NLC GGC repeat expansion causes retinal pathology with intranuclear inclusions throughout the retina and causes visual impairment.

Diffusion weighted image GGC repeat Gliosis Leukoencephalopathy NOTCH2NLC Neuronal intranuclear inclusion disease Retinal pathology Retinitis Pigmentosa p-62

Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
02 05 2023
Historique:
received: 19 02 2023
accepted: 10 04 2023
medline: 4 5 2023
pubmed: 3 5 2023
entrez: 2 5 2023
Statut: epublish

Résumé

The retinal pathology of genetically confirmed neuronal intranuclear inclusion disease (NIID) is yet unknown. We report the ocular findings in four NIID patients with NOTCH2NLC GGC repeat expansion to investigate the pathology of retinopathy. All four NIID patients were diagnosed by skin biopsy and NOTCH2NLC GGC repeat analysis. Ocular findings in patients with NIID were studied using fundus photographs, optical coherence tomographic images (OCT), and full-field electroretinograms (ERGs). The histopathology of the retina was studied on autopsy samples from two cases with immunohistochemistry. All patients had an expansion of the GGC repeat (87-134 repeats) in the NOTCH2NLC. Two patients were legally blind and had been diagnosed with retinitis pigmentosa prior to the diagnosis of NIID and assessed with whole exome sequencing to rule out comorbidity with other retinal diseases. Fundus photographs around the posterior pole showed chorioretinal atrophy in the peripapillary regions. OCT showed thinning of the retina. ERGs showed various abnormalities in cases. The histopathology of autopsy samples showed diffusely scattered intranuclear inclusions throughout the retina from the retinal pigment epithelium to the ganglion cell layer, and optic nerve glial cells. And severe gliosis was observed in retina and optic nerve. The NOTCH2NLC GGC repeat expansion causes numerous intranuclear inclusions in the retina and optic nerve cells and gliosis. Visual dysfunction could be the first sign of NIID. We should consider NIID as one of the causes of retinal dystrophy and investigate the GGC repeat expansion in NOTCH2NLC.

Identifiants

pubmed: 37131242
doi: 10.1186/s40478-023-01564-3
pii: 10.1186/s40478-023-01564-3
pmc: PMC10152767
doi:

Substances chimiques

NOTCH2 protein, human 0
Receptor, Notch2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

71

Informations de copyright

© 2023. The Author(s).

Références

Neuron. 2021 Jun 2;109(11):1825-1835.e5
pubmed: 33887199
Acta Neuropathol. 2013 Jul;126(1):1-19
pubmed: 23793382
Arch Ophthalmol. 1997 Feb;115(2):231-6
pubmed: 9046258
J Med Genet. 2019 Oct;56(10):662-670
pubmed: 31213501
Intern Med. 2018 Dec 1;57(23):3459-3462
pubmed: 30101925
Acta Neuropathol. 1968 Jan 2;10(1):54-73
pubmed: 4295804
Am J Hum Genet. 2020 Jun 4;106(6):793-804
pubmed: 32413282
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):27
pubmed: 32931575
Nat Genet. 2019 Aug;51(8):1215-1221
pubmed: 31332381
Ophthalmic Genet. 2020 Feb;41(1):93-95
pubmed: 32039647
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Neurobiol Dis. 2022 Aug;170:105774
pubmed: 35605759
Arch Ophthalmol. 1991 Mar;109(3):373-8
pubmed: 1848426
Brain. 2016 Dec;139(Pt 12):3170-3186
pubmed: 27797808
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Acta Neuropathol. 1981;54(2):113-9
pubmed: 6264727
Acta Neuropathol. 2008 Dec;116(6):615-23
pubmed: 18923837
Neurol Sci. 2022 May;43(5):3231-3237
pubmed: 34797461
Nucleic Acids Res. 2021 Jan 8;49(D1):D536-D544
pubmed: 33179747
Eur J Hum Genet. 2004 Jan;12(1):2-15
pubmed: 14571264
Nat Genet. 1998 Jan;18(1):72-5
pubmed: 9425905
Doc Ophthalmol. 2015 Feb;130(1):1-12
pubmed: 25502644
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):354-6
pubmed: 24039026
J Formos Med Assoc. 2021 Sep;120(9):1793-1795
pubmed: 33858738
Nat Genet. 2019 Aug;51(8):1222-1232
pubmed: 31332380
Neuropathology. 2003 Dec;23(4):351-9
pubmed: 14719553
Ann Neurol. 1984 Apr;15(4):316-21
pubmed: 6331275
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
Am J Hum Genet. 2019 Jul 3;105(1):166-176
pubmed: 31178126
Neurology. 2005 Nov 22;65(10):1538-43
pubmed: 16301479
Acta Neuropathol Commun. 2020 Jun 3;8(1):75
pubmed: 32493488
Acta Ophthalmol (Copenh). 1986 Dec;64(6):637-43
pubmed: 3028034
Neurology. 2011 Apr 19;76(16):1372-6
pubmed: 21411744
Neurology. 1986 Jun;36(6):785-90
pubmed: 3010181
Doc Ophthalmol. 2017 Jun;134(3):221-226
pubmed: 28332008
Acta Neuropathol. 2005 Nov;110(5):523-5
pubmed: 16222522
Intern Med. 2016;55(16):2281-4
pubmed: 27523009
J Neurol Sci. 2018 May 15;388:84-86
pubmed: 29627037

Auteurs

Jun Sone (J)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan. jsone@aichi-med-u.ac.jp.
Department of Neurology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan. jsone@aichi-med-u.ac.jp.
Department of Neurology, National Hospital Organization Suzuka National Hospital, 3-2-1, Kasado, Suzuka, Mie, 513-8501, Japan. jsone@aichi-med-u.ac.jp.
Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan. jsone@aichi-med-u.ac.jp.

Shinji Ueno (S)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.
Department of Ophthalmology, Hirosaki University Graduate School of Medicine, 5 Zaifu, Hirosaki, Aomori, 036-8562, Japan.

Akio Akagi (A)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Hiroaki Miyahara (H)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Chisato Tamai (C)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Yuichi Riku (Y)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.

Hiroyuki Yabata (H)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
Department of Neurology, Shiga University of Medical Science. Seta-Tsukinowa, Otsu, 520-2192, Japan.

Ryuichi Koizumi (R)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 22-2 Seto, Kanazawa-Ku, Yokohama, Kanagawa, 236-0027, Japan.

Tomohiro Hattori (T)

Department of Ophthalmology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan.

Hiroshi Hirose (H)

Department of Ophthalmology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan.

Yoshito Koyanagi (Y)

Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.
Department of Ophthalmology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan.

Rei Kobayashi (R)

Department of Neurology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan.

Hisashi Okada (H)

Department of Neurology, National Hospital Organization Nagoya Medical Center, 4-1-1, Sannomaru, Naka-Ku, Nagoya, Aichi, 460-0001, Japan.

Yoshiyuki Kishimoto (Y)

Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.

Yoshio Hashizume (Y)

Department of Neuropathology, Choju Medical Institute, Fukushimura Hospital, 19-14, Yamanaka, Noyori, Toyohashi, Aichi, 441-8124, Japan.

Gen Sobue (G)

Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-Ku, Nagoya, Aichi, 466-8560, Japan.
Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Mari Yoshida (M)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Yasushi Iwasaki (Y)

Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH